Literature DB >> 15685651

Measurement of caffeine and five of the major metabolites in urine by high-performance liquid chromatography/tandem mass spectrometry.

Allan Weimann1, Mads Sabroe, Henrik E Poulsen.   

Abstract

Analysis of caffeine and its metabolites is of interest with respect to caffeine exposure, for kinetic and metabolism studies and for opportunistic in vivo estimation of drug metabolizing enzyme activity in humans and animals. For the latter, analysis is usually done by high-performance liquid chromatography (HPLC) with UV detection. However, this method is close to the detection limit for certain of the metabolites and requires very long chromatography, 30-60 min. We have developed a fast method for the quantification of caffeine and its metabolites 1-methylxanthine, 1-methyluric acid, 1,7-dimethyluric acid, 5-acetylamino-6-amino-3-methyluracil (AAMU) and 5-acetylamino-6-formylamino-3-methyluracil (AFMU) by HPLC tandem mass spectrometry (MS/MS) in urine that requires only its dilution with buffer and centrifugation before injection into the HPLC/MS/MS system. The chromatography lasts 7 min and is followed by 4.5 min for re-equilibration of the HPLC column, giving a total analysis time of 11.5 min. The method provides a great sensitivity improvement with detection limits for all analytes <or=25 nM in real samples. Also, the analysis provides much improvement in capacity to approximately 125 samples per 24 h. Intra- and inter-day coefficients of variation of a single analysis are <6.5% for all the analytes. The inter-day coefficient of variation of duplicate analyses is <4.8% for all analytes. The method is automated, including automated integration, and it is fast, robust and suitable for large-scale investigations in humans and animals. Copyright (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15685651     DOI: 10.1002/jms.785

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  9 in total

1.  Cigarette smoking behaviour and blood metabolomics.

Authors:  Fangyi Gu; Andriy Derkach; Neal D Freedman; Maria Teresa Landi; Demetrius Albanes; Stephanie J Weinstein; Alison M Mondul; Charles E Matthews; Kristin A Guertin; Qian Xiao; Wei Zheng; Xiao-Ou Shu; Joshua N Sampson; Steven C Moore; Neil E Caporaso
Journal:  Int J Epidemiol       Date:  2015-12-31       Impact factor: 7.196

2.  Altered xanthine oxidase and N-acetyltransferase activity in obese children.

Authors:  Manoj S Chiney; Sarah J Schwarzenberg; L'aurelle A Johnson
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

Review 3.  High-performance liquid chromatography-tandem mass spectrometry in the identification and determination of phase I and phase II drug metabolites.

Authors:  M Holcapek; L Kolárová; M Nobilis
Journal:  Anal Bioanal Chem       Date:  2008-03-15       Impact factor: 4.142

4.  The fecal metabolome as a functional readout of the gut microbiome.

Authors:  Jonas Zierer; Matthew A Jackson; Gabi Kastenmüller; Massimo Mangino; Tao Long; Amalio Telenti; Robert P Mohney; Kerrin S Small; Jordana T Bell; Claire J Steves; Ana M Valdes; Tim D Spector; Cristina Menni
Journal:  Nat Genet       Date:  2018-05-28       Impact factor: 38.330

5.  A Prospective Randomized, Double-Blind, Two-Period Crossover Pharmacokinetic Trial Comparing Green Coffee Bean Extract-A Botanically Sourced Caffeine-With a Synthetic USP Control.

Authors:  Kayce Morton; Katelin Knight; Douglas Kalman; Susan Hewlings
Journal:  Clin Pharmacol Drug Dev       Date:  2018-04-16

6.  Plasma Metabolites Associated with Coffee Consumption: A Metabolomic Approach within the PREDIMED Study.

Authors:  Christopher Papandreou; Pablo Hernández-Alonso; Mònica Bulló; Miguel Ruiz-Canela; Edward Yu; Marta Guasch-Ferré; Estefanía Toledo; Courtney Dennis; Amy Deik; Clary Clish; Cristina Razquin; Dolores Corella; Ramon Estruch; Emilio Ros; Montserrat Fitó; Fernando Arós; Miquel Fiol; José Lapetra; Cristina Ruano; Liming Liang; Miguel A Martínez-González; Frank B Hu; Jordi Salas-Salvadó
Journal:  Nutrients       Date:  2019-05-08       Impact factor: 5.717

7.  Serum Metabolomics Identifies Altered Bioenergetics, Signaling Cascades in Parallel with Exposome Markers in Crohn's Disease.

Authors:  Yunjia Lai; Jingchuan Xue; Chih-Wei Liu; Bei Gao; Liang Chi; Pengcheng Tu; Kun Lu; Hongyu Ru
Journal:  Molecules       Date:  2019-01-27       Impact factor: 4.411

8.  Determination of Urinary Caffeine Metabolites as Biomarkers for Drug Metabolic Enzyme Activities.

Authors:  Hyeong Jun Kim; Min Sun Choi; Shaheed Ur Rehman; Young Seok Ji; Jun Sang Yu; Katsunori Nakamura; Hye Hyun Yoo
Journal:  Nutrients       Date:  2019-08-19       Impact factor: 5.717

9.  Chemoreceptors of Escherichia coli CFT073 play redundant roles in chemotaxis toward urine.

Authors:  Erica L Raterman; Rodney A Welch
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.